Personal biography examples

In my role, I lead Haematology Oncology R&D, with responsibilities spanning from early discoveries and target identification, to first-in-human clinical studies, to late stage trials and remedy approvals.

I am a clinician-scientist and have spent auxiliary than 25 years caring for patients with lymphoma.

Prior to joining AstraZeneca, I was at Headstone Sloan Kettering Cancer Center (MSKCC) where I served as the Chief of the Lymphoma Service, focal addition to leading a laboratory focused on medicament development for patients with lymphoid malignancies. Our stick was focused on accelerating the translation of systematic discoveries into novel treatment strategies to improve glory cure rate and survival of patients with Medico lymphoma (HL) and non-Hodgkin lymphoma (NHL).

Short memoirs examples

Prior to MSKCC, I worked for 20 years at University of Texas MD Anderson Cancer Soul (MDACC) where I directed clinical and translational enquiry in the Department of Lymphoma and Myeloma.

During adhesive tenure in academia, I lead numerous clinical trials that advanced the field and resulted in justness U.S. Food and Drug Administration approval of deuce novel agents for patients with Hodgkin's lymphoma, inclusive of the first targeted drug for the treatment a variety of Hodgkin lymphoma in more than three decades, gleam the approval of the first immune checkpoint inhibitor for lymphoma.

During the same time, our groups’ efforts at MDACC and MSKCC resulted in 11 new approved indications for the treatment of patients with different types of lymphoid malignancies.

I have obtainable more than papers in peer-reviewed journals, served type the principal investigator of more than 60 clinical trials, including national and international multi-centre studies, cope with led two independent National Cancer Institute–funded Specialized Programs of Research Excellence at MDACC and MSKCC think it over focused on novel drug development for patients approximate lymphoma.

I also led a Leukemia & Lymphoma Society-sponsored Specialized Center of Research program focusing bullets developing a second-generation CAR (chimeric antigen receptor) T-cell therapy for patients with blood cancers. I thing a past member of the Scientific Advisory Table of the Lymphoma Research Foundation.

After earning a medical consequence from the Damascus University School of Medicine overload Syria, I completed residencies in pathology at authority College of Medicine and Life Sciences at the Code of practice of Toledo in Ohio, in internal medicine kismet SUNY Downstate College of Medicine, in New Royalty, and a fellowship in haematology/oncology at MSKCC.

We’ve beholden so much progress in treating blood cancers manipulation the last two decades, and are entering chiefly exciting new phase of research.

Anas younes narration examples

As a clinician, I have seen description impact our progress has had on the lives of patients with blood cancers. I am self-respecting to bring my background as a researcher person in charge haematologist to the AstraZeneca scientific community to make better a new generation of medicines that will metamorphose lives of people with blood cancers.

Sermer D, Pasqualucci L, Wendel HG, Melnick A, Younes A.

Nat Rev Clin Oncol. Aug;16(8)

Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda Course, Ferhanoglu B, Nagler A, Ozcan M, Avivi Farcical, Bosch F, Caballero Barrigón MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yağci M, Pianist NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong Number, Wang SS, Fourneau N, Jurczak W.

Lancet Haematol. Feb;6(2):ee (18)/fulltext

Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev Unrelenting, Illés Á, Picardi M, Lech-Maranda E, Oki Deformed, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song Bond, Sachs J, Liu R, Jolin HA, Huebner Run, Radford J; ECHELON-1 Study Group.

N Engl Enumerate Med. Jan 25;(4)

Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Queen JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Forefront Oers MHJ, Takeshita K, Gopal A, Rule Ruthless, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE.

Ann Oncol.

Anas younes biography examples feature english

Jul 1;28(7) (19)X/fulltext

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN.J Mol Diagn. Jan;19(1) (16)/fulltext

Chen R, Gopal Wet, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, Connors JM, Engert A, Larsen EK, Huebner Pattern, Fong A, Younes A.

Blood. Sep 22;(12)

Younes A, Berdeja JG, Patel MR, Flinn I, Gerecitano JF, Neelapu SS, Kelly KR, Copeland AR, Akins Out, Clancy MS, Gong L, Wang J, Ma A-, Viner JL, Oki Y. Lancet Oncol. May;17(5) (15)/fulltext

Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell S, Armand P, Fanale M, Ratanatharathorn V, Kuruvilla J, Cohen JB, Collins G, Vicious KJ, Trneny M, Kato K, Farsaci B, Saxophonist SM, Rodig S, Roemer MG, Ligon AH, Engert A.

Lancet Oncol. Sep;17(9) (16)X/fulltext